Home Pharmaceuticals Pain Management Drugs Market Size Projected to Grow at a CAGR of 3.5% by 2031

Pain Management Drugs Market Size, Share & Trends Analysis Report By Drug Class (NSAIDS, Anesthetics, Anticonvulsants, Antimigraine Agents, Antidepressants, Opioids, Nonnarcotic Analgesics), By Pain type (Chronic pain, Acute pain), By Indication (Arthritic Pain, Neuropathic Pain, Cancer Pain, Chronic Back Pain, Postoperative Pain, Migraine, Fibromyalgia, Bone fracture, Muscle sprain/strain, Acute appendicitis, Others) and By Region(North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2023-2031

Report Code: SRPH54234DR
Last Updated : Apr 28, 2023
Author : Straits Research
Starting From
USD 2300
Buy Now

Table Of Content

  1. Executive Summary

    1. Research Objectives
    2. Limitations & Assumptions
    3. Market Scope & Segmentation
    4. Currency & Pricing Considered
    1. Emerging Regions / Countries
    2. Emerging Companies
    3. Emerging Applications / End Use
    1. Drivers
    2. Market Warning Factors
    3. Latest Macro Economic Indicators
    4. Geopolitical Impact
    5. Technology Factors
    1. Porters Five Forces Analysis
    2. Value Chain Analysis
    1. North America
    2. Europe
    3. APAC
    4. Middle East and Africa
    5. LATAM
  2. ESG Trends

    1. Global Pain Management Drugs Market Introduction
    2. By Drug Class
      1. Introduction
        1. Drug Class By Value
      2. NSAIDS
        1. By Value
      3. Anesthetics
        1. By Value
      4. Anticonvulsants
        1. By Value
      5. Antimigraine Agents
        1. By Value
      6. Antidepressants
        1. By Value
      7. Opioids
        1. By Value
      8. Nonnarcotic Analgesics
        1. By Value
    3. By Pain type
      1. Introduction
        1. Pain type By Value
      2. Chronic pain
        1. By Value
      3. Acute pain
        1. By Value
    4. By Indication
      1. Introduction
        1. Indication By Value
      2. Arthritic Pain
        1. By Value
      3. Neuropathic Pain
        1. By Value
      4. Cancer Pain
        1. By Value
      5. Chronic Back Pain
        1. By Value
      6. Postoperative Pain
        1. By Value
      7. Migraine
        1. By Value
      8. Fibromyalgia
        1. By Value
      9. Bone fracture
        1. By Value
      10. Muscle sprain/strain
        1. By Value
      11. Acute appendicitis
        1. By Value
      12. Others
        1. By Value
    1. Introduction
    2. By Drug Class
      1. Introduction
        1. Drug Class By Value
      2. NSAIDS
        1. By Value
      3. Anesthetics
        1. By Value
      4. Anticonvulsants
        1. By Value
      5. Antimigraine Agents
        1. By Value
      6. Antidepressants
        1. By Value
      7. Opioids
        1. By Value
      8. Nonnarcotic Analgesics
        1. By Value
    3. By Pain type
      1. Introduction
        1. Pain type By Value
      2. Chronic pain
        1. By Value
      3. Acute pain
        1. By Value
    4. By Indication
      1. Introduction
        1. Indication By Value
      2. Arthritic Pain
        1. By Value
      3. Neuropathic Pain
        1. By Value
      4. Cancer Pain
        1. By Value
      5. Chronic Back Pain
        1. By Value
      6. Postoperative Pain
        1. By Value
      7. Migraine
        1. By Value
      8. Fibromyalgia
        1. By Value
      9. Bone fracture
        1. By Value
      10. Muscle sprain/strain
        1. By Value
      11. Acute appendicitis
        1. By Value
      12. Others
        1. By Value
    5. U.S.
      1. By Drug Class
        1. Introduction
          1. Drug Class By Value
        2. NSAIDS
          1. By Value
        3. Anesthetics
          1. By Value
        4. Anticonvulsants
          1. By Value
        5. Antimigraine Agents
          1. By Value
        6. Antidepressants
          1. By Value
        7. Opioids
          1. By Value
        8. Nonnarcotic Analgesics
          1. By Value
      2. By Pain type
        1. Introduction
          1. Pain type By Value
        2. Chronic pain
          1. By Value
        3. Acute pain
          1. By Value
      3. By Indication
        1. Introduction
          1. Indication By Value
        2. Arthritic Pain
          1. By Value
        3. Neuropathic Pain
          1. By Value
        4. Cancer Pain
          1. By Value
        5. Chronic Back Pain
          1. By Value
        6. Postoperative Pain
          1. By Value
        7. Migraine
          1. By Value
        8. Fibromyalgia
          1. By Value
        9. Bone fracture
          1. By Value
        10. Muscle sprain/strain
          1. By Value
        11. Acute appendicitis
          1. By Value
        12. Others
          1. By Value
    6. Canada
    1. Introduction
    2. By Drug Class
      1. Introduction
        1. Drug Class By Value
      2. NSAIDS
        1. By Value
      3. Anesthetics
        1. By Value
      4. Anticonvulsants
        1. By Value
      5. Antimigraine Agents
        1. By Value
      6. Antidepressants
        1. By Value
      7. Opioids
        1. By Value
      8. Nonnarcotic Analgesics
        1. By Value
    3. By Pain type
      1. Introduction
        1. Pain type By Value
      2. Chronic pain
        1. By Value
      3. Acute pain
        1. By Value
    4. By Indication
      1. Introduction
        1. Indication By Value
      2. Arthritic Pain
        1. By Value
      3. Neuropathic Pain
        1. By Value
      4. Cancer Pain
        1. By Value
      5. Chronic Back Pain
        1. By Value
      6. Postoperative Pain
        1. By Value
      7. Migraine
        1. By Value
      8. Fibromyalgia
        1. By Value
      9. Bone fracture
        1. By Value
      10. Muscle sprain/strain
        1. By Value
      11. Acute appendicitis
        1. By Value
      12. Others
        1. By Value
    5. U.K.
      1. By Drug Class
        1. Introduction
          1. Drug Class By Value
        2. NSAIDS
          1. By Value
        3. Anesthetics
          1. By Value
        4. Anticonvulsants
          1. By Value
        5. Antimigraine Agents
          1. By Value
        6. Antidepressants
          1. By Value
        7. Opioids
          1. By Value
        8. Nonnarcotic Analgesics
          1. By Value
      2. By Pain type
        1. Introduction
          1. Pain type By Value
        2. Chronic pain
          1. By Value
        3. Acute pain
          1. By Value
      3. By Indication
        1. Introduction
          1. Indication By Value
        2. Arthritic Pain
          1. By Value
        3. Neuropathic Pain
          1. By Value
        4. Cancer Pain
          1. By Value
        5. Chronic Back Pain
          1. By Value
        6. Postoperative Pain
          1. By Value
        7. Migraine
          1. By Value
        8. Fibromyalgia
          1. By Value
        9. Bone fracture
          1. By Value
        10. Muscle sprain/strain
          1. By Value
        11. Acute appendicitis
          1. By Value
        12. Others
          1. By Value
    6. Germany
    7. France
    8. Spain
    9. Italy
    10. Russia
    11. Nordic
    12. Benelux
    13. Rest of Europe
    1. Introduction
    2. By Drug Class
      1. Introduction
        1. Drug Class By Value
      2. NSAIDS
        1. By Value
      3. Anesthetics
        1. By Value
      4. Anticonvulsants
        1. By Value
      5. Antimigraine Agents
        1. By Value
      6. Antidepressants
        1. By Value
      7. Opioids
        1. By Value
      8. Nonnarcotic Analgesics
        1. By Value
    3. By Pain type
      1. Introduction
        1. Pain type By Value
      2. Chronic pain
        1. By Value
      3. Acute pain
        1. By Value
    4. By Indication
      1. Introduction
        1. Indication By Value
      2. Arthritic Pain
        1. By Value
      3. Neuropathic Pain
        1. By Value
      4. Cancer Pain
        1. By Value
      5. Chronic Back Pain
        1. By Value
      6. Postoperative Pain
        1. By Value
      7. Migraine
        1. By Value
      8. Fibromyalgia
        1. By Value
      9. Bone fracture
        1. By Value
      10. Muscle sprain/strain
        1. By Value
      11. Acute appendicitis
        1. By Value
      12. Others
        1. By Value
    5. China
      1. By Drug Class
        1. Introduction
          1. Drug Class By Value
        2. NSAIDS
          1. By Value
        3. Anesthetics
          1. By Value
        4. Anticonvulsants
          1. By Value
        5. Antimigraine Agents
          1. By Value
        6. Antidepressants
          1. By Value
        7. Opioids
          1. By Value
        8. Nonnarcotic Analgesics
          1. By Value
      2. By Pain type
        1. Introduction
          1. Pain type By Value
        2. Chronic pain
          1. By Value
        3. Acute pain
          1. By Value
      3. By Indication
        1. Introduction
          1. Indication By Value
        2. Arthritic Pain
          1. By Value
        3. Neuropathic Pain
          1. By Value
        4. Cancer Pain
          1. By Value
        5. Chronic Back Pain
          1. By Value
        6. Postoperative Pain
          1. By Value
        7. Migraine
          1. By Value
        8. Fibromyalgia
          1. By Value
        9. Bone fracture
          1. By Value
        10. Muscle sprain/strain
          1. By Value
        11. Acute appendicitis
          1. By Value
        12. Others
          1. By Value
    6. Korea
    7. Japan
    8. India
    9. Australia
    10. Taiwan
    11. South East Asia
    12. Rest of Asia-Pacific
    1. Introduction
    2. By Drug Class
      1. Introduction
        1. Drug Class By Value
      2. NSAIDS
        1. By Value
      3. Anesthetics
        1. By Value
      4. Anticonvulsants
        1. By Value
      5. Antimigraine Agents
        1. By Value
      6. Antidepressants
        1. By Value
      7. Opioids
        1. By Value
      8. Nonnarcotic Analgesics
        1. By Value
    3. By Pain type
      1. Introduction
        1. Pain type By Value
      2. Chronic pain
        1. By Value
      3. Acute pain
        1. By Value
    4. By Indication
      1. Introduction
        1. Indication By Value
      2. Arthritic Pain
        1. By Value
      3. Neuropathic Pain
        1. By Value
      4. Cancer Pain
        1. By Value
      5. Chronic Back Pain
        1. By Value
      6. Postoperative Pain
        1. By Value
      7. Migraine
        1. By Value
      8. Fibromyalgia
        1. By Value
      9. Bone fracture
        1. By Value
      10. Muscle sprain/strain
        1. By Value
      11. Acute appendicitis
        1. By Value
      12. Others
        1. By Value
    5. UAE
      1. By Drug Class
        1. Introduction
          1. Drug Class By Value
        2. NSAIDS
          1. By Value
        3. Anesthetics
          1. By Value
        4. Anticonvulsants
          1. By Value
        5. Antimigraine Agents
          1. By Value
        6. Antidepressants
          1. By Value
        7. Opioids
          1. By Value
        8. Nonnarcotic Analgesics
          1. By Value
      2. By Pain type
        1. Introduction
          1. Pain type By Value
        2. Chronic pain
          1. By Value
        3. Acute pain
          1. By Value
      3. By Indication
        1. Introduction
          1. Indication By Value
        2. Arthritic Pain
          1. By Value
        3. Neuropathic Pain
          1. By Value
        4. Cancer Pain
          1. By Value
        5. Chronic Back Pain
          1. By Value
        6. Postoperative Pain
          1. By Value
        7. Migraine
          1. By Value
        8. Fibromyalgia
          1. By Value
        9. Bone fracture
          1. By Value
        10. Muscle sprain/strain
          1. By Value
        11. Acute appendicitis
          1. By Value
        12. Others
          1. By Value
    6. Turkey
    7. Saudi Arabia
    8. South Africa
    9. Egypt
    10. Nigeria
    11. Rest of MEA
    1. Introduction
    2. By Drug Class
      1. Introduction
        1. Drug Class By Value
      2. NSAIDS
        1. By Value
      3. Anesthetics
        1. By Value
      4. Anticonvulsants
        1. By Value
      5. Antimigraine Agents
        1. By Value
      6. Antidepressants
        1. By Value
      7. Opioids
        1. By Value
      8. Nonnarcotic Analgesics
        1. By Value
    3. By Pain type
      1. Introduction
        1. Pain type By Value
      2. Chronic pain
        1. By Value
      3. Acute pain
        1. By Value
    4. By Indication
      1. Introduction
        1. Indication By Value
      2. Arthritic Pain
        1. By Value
      3. Neuropathic Pain
        1. By Value
      4. Cancer Pain
        1. By Value
      5. Chronic Back Pain
        1. By Value
      6. Postoperative Pain
        1. By Value
      7. Migraine
        1. By Value
      8. Fibromyalgia
        1. By Value
      9. Bone fracture
        1. By Value
      10. Muscle sprain/strain
        1. By Value
      11. Acute appendicitis
        1. By Value
      12. Others
        1. By Value
    5. Brazil
      1. By Drug Class
        1. Introduction
          1. Drug Class By Value
        2. NSAIDS
          1. By Value
        3. Anesthetics
          1. By Value
        4. Anticonvulsants
          1. By Value
        5. Antimigraine Agents
          1. By Value
        6. Antidepressants
          1. By Value
        7. Opioids
          1. By Value
        8. Nonnarcotic Analgesics
          1. By Value
      2. By Pain type
        1. Introduction
          1. Pain type By Value
        2. Chronic pain
          1. By Value
        3. Acute pain
          1. By Value
      3. By Indication
        1. Introduction
          1. Indication By Value
        2. Arthritic Pain
          1. By Value
        3. Neuropathic Pain
          1. By Value
        4. Cancer Pain
          1. By Value
        5. Chronic Back Pain
          1. By Value
        6. Postoperative Pain
          1. By Value
        7. Migraine
          1. By Value
        8. Fibromyalgia
          1. By Value
        9. Bone fracture
          1. By Value
        10. Muscle sprain/strain
          1. By Value
        11. Acute appendicitis
          1. By Value
        12. Others
          1. By Value
    6. Mexico
    7. Argentina
    8. Chile
    9. Colombia
    10. Rest of LATAM
    1. Pain Management Drugs Market Share By Players
    2. M&A Agreements & Collaboration Analysis
    1. Novartis AG
      1. Overview
      2. Business Information
      3. Revenue
      4. ASP
      5. SWOT Analysis
      6. Recent Developments
    2. Purdue Pharma L.P.
    3. Eli Lilly & Company
    4. Abbott Laboratories
    5. Endo Health Solutions Inc.
    6. Pfizer Inc.
    7. Mylan NV.
    8. Merck & Co. Inc.
    9. Johnson & Johnson
    10. GlaxoSmithKline Plc.
    11. Allergen Inc.
    12. Bayer AG
    13. Bristol-Myers Squibb
    14. Sorrento Therapeutics
    15. Valeant Pharmaceuticals International Inc.
    16. Boehringer Ingelheim
    17. WEX Pharmaceuticals
    18. Zynerba Pharmaceuticals
    1. Research Data
      1. Secondary Data
        1. Major secondary sources
        2. Key data from secondary sources
      2. Primary Data
        1. Key data from primary sources
        2. Breakdown of primaries
      3. Secondary And Primary Research
        1. Key industry insights
    2. Market Size Estimation
      1. Bottom-Up Approach
      2. Top-Down Approach
      3. Market Projection
    3. Research Assumptions
      1. Assumptions
    4. Limitations
    5. Risk Assessment
    1. Discussion Guide
    2. Customization Options
    3. Related Reports
  3. Disclaimer

Related Reports

Global Report
The global airway management devices market size was valued at USD 1.7 billion in 2023 and is projected to reach USD 2.8 billion by 2032, registering a CAGR of 5.2% during the forecast period (2024-2032). The increasing frequency of respiratory disor
Buy Now
Global Report
API Management Market SizeThe global API management market size was valued at USD 1.16 billion in 2021. It is expected to reach USD 7.02 billion, growing at a CAGR of 22.15% during the forecast period (2022–2030). Companies can expand their market po
Buy Now
Global Report
The global casino management system market size was valued at USD 7.65 billion in 2023. It is estimated to reach USD 29.61 billion by 2032, growing at a CAGR of 13.12% during the forecast period (2024–2032). Advancements in technology, includin
Buy Now
Global Report
Pain Management Therapeutics Market Size The global pain management therapeutics market size was valued at USD 79.42 billion in 2023 and is projected to reach USD 115.21 billion by 2032, growing at a CAGR of 4.22% during the
Buy Now
Global Report
Market Overview The global parking management market size was valued at USD 4.56 billion in 2022 and is projected to reach USD 11.48 billion by 2031, registering a CAGR of 10.8% during the forecast period 2023-2031. Parking managemen
Buy Now

Purchase Benefits

  • Eligible for a free updated report next year
  • Completely customizable scope
  • 30% discount on your next purchase
  • Dedicated account manager
  • Query resolution within 24 hours
  • Permission to print the report


We are featured on :